Solid-state NMR investigations of peptide-lipid interaction and orientation of a ß-sheet antimicrobial peptide, protegrin

被引:146
作者
Yamaguchi, S
Hong, T
Waring, A
Lehrer, RI
Hong, M [1 ]
机构
[1] Iowa State Univ Sci & Technol, Dept Chem, Ames, IA 50011 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA
关键词
D O I
10.1021/bi0257991
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protegrin-1 (PG-1) is a broad-spectrum beta-sheet antimicrobial peptide found in porcine leukocytes. The mechanism of action and the orientation of PG-1 in lipid bilayers are here investigated using H-2, P-31, C-13, and N-15 solid-state NMR spectroscopy. H-2 spectra of mechanically aligned and chain-perdeuterated 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC) bilayers indicate that PG-I at high concentrations destroys the orientational order of the aligned lamellar bilayer. The conformation of the lipid headgroups in the unoriented region is significantly altered, as seen from the P-31 spectra of POPC and the H-2 spectra of headgroup-deuterated 1,2-dipalniitoyl-sn-glycero-3-phosphatidylcholine. These observations indicate that PG-1 disrupts microbial membranes by breaking the extended bilayer into smaller disks, where a significant fraction of lipids is located in the edges of the disks with a distribution of orientations. These edges allow the lipid bilayer to bend back on itself as in toroidal pores. Interestingly, this loss of bilayer orientation occurs only in long-chain lipids such as POPC and not in shorter chain lipids such as 1,2-dilauroyl-sn-glycero-3-phosphatidylcholine (DLPC). To understand the mode of binding of PG-I to the lipid bilayer, we determined the orientation of PG-I in DLPC bilayers. The (CO)-C-13 and 15N chemical shifts of Val-16 labeled PG-1 indicate that the beta-strand axis is tilted by 55degrees +/- 5degrees from the bilayer normal while the normal of the beta-sheet plane is 48degrees +/- 5degrees from the bilayer normal. This orientation favors interaction of the hydrophobic backbone of the peptide with the hydrophobic core of the bilayer and positions the cationic Arg side chains to interact with the anionic phosphate groups. This is the first time that the orientation of a disulfide-stabilized beta-sheet membrane peptide has been determined by solid-state NMR.
引用
收藏
页码:9852 / 9862
页数:11
相关论文
共 64 条
[1]   INTERACTION OF METAL-IONS WITH PHOSPHATIDYLCHOLINE BILAYER-MEMBRANES [J].
AKUTSU, H ;
SEELIG, J .
BIOCHEMISTRY, 1981, 20 (26) :7366-7373
[2]   CA-2+ BINDING TO PHOSPHATIDYLCHOLINE BILAYERS AS STUDIED BY DEUTERIUM MAGNETIC-RESONANCE - EVIDENCE FOR THE FORMATION OF A CA-2+ COMPLEX WITH 2 PHOSPHOLIPIDMOLECULES [J].
ALTENBACH, C ;
SEELIG, J .
BIOCHEMISTRY, 1984, 23 (17) :3913-3920
[3]   Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of β-sheets in Alzheimer's β-amyloid fibrils [J].
Antzutkin, ON ;
Balbach, JJ ;
Leapman, RD ;
Rizzo, NW ;
Reed, J ;
Tycko, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) :13045-13050
[4]   Synthesis and solution structure of the antimicrobial peptide protegrin-1 [J].
Aumelas, A ;
Mangoni, M ;
Roumestand, C ;
Chiche, L ;
Despaux, E ;
Grassy, G ;
Calas, B ;
Chavanieu, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 237 (03) :575-583
[5]   The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy [J].
Bechinger, B .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1462 (1-2) :157-183
[6]   Structure and dynamics of the antibiotic peptide PGLa in membranes by solution and solid-state nuclear magnetic resonance spectroscopy [J].
Bechinger, B ;
Zasloff, M ;
Opella, SJ .
BIOPHYSICAL JOURNAL, 1998, 74 (02) :981-987
[7]   STRUCTURE AND ORIENTATION OF THE ANTIBIOTIC PEPTIDE MAGAININ IN MEMBRANES BY SOLID-STATE NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY [J].
BECHINGER, B ;
ZASLOFF, M ;
OPELLA, SJ .
PROTEIN SCIENCE, 1993, 2 (12) :2077-2084
[8]  
Chen J, 2000, BIOPOLYMERS, V55, P88, DOI 10.1002/1097-0282(2000)55:1<88::AID-BIP80>3.0.CO
[9]  
2-K
[10]  
Cross TA, 1997, METHOD ENZYMOL, V289, P672